Current Status of Baricitinib as a Repurposed Therapy for COVID-19

• Glavni autori: Maha Saber-Ayad (Autor), Sarah Hammoudeh (Autor), Eman Abu-Gharbieh (Autor), Rifat Hamoudi (Autor), Hamadeh Tarazi (Autor), Taleb H. Al-Tel (Autor), Qutayba Hamid (Autor)
• Format: Knjiga
• Izdano: MDPI AG, 2021-07-01T00:00:00Z.
• Teme: article
• Online pristup: Connect to this object online.

The emergence of the COVID-19 pandemic has mandated the instant (re)search for potential drug candidates. In response to the unprecedented situation, it was recognized early that repurposing of available drugs in the market could timely save lives, by skipping the lengthy phases of preclinical and i...